Results 171 to 180 of about 26,563 (215)
Some of the next articles are maybe not open access.
Rocuronium and malignant hyperthermia
American Journal of Health-System Pharmacy, 2012Beggs et al.[1][1] presented two interesting case reports postulating an association between rocuronium and malignant hyperthermia (MH). Although the observed fever in these patients declined after discontinuation of rocuronium, several points need further discussion.
Frank, Schuster, Stephan, Johannsen
openaire +2 more sources
Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.
Middle East journal of anaesthesiology, 2007The present report evaluates the incidence of pain on intravenous injection and the condition of tracheal intubation at one minute following the administration of cisatracurium or rocuronium versus rocuronium-cisatracurium combination. We studied 60 patients, ASA 1, aged 18-60 years, undergoing elective surgical procedures.
Ahed, Zeidan +3 more
openaire +1 more source
Revista espanola de anestesiologia y reanimacion, 1998
Rocuronium is a new nondepolarizing neuromuscular blocking agent (NDNMBA) that has recently been introduced for clinical use. Its main advantage over other such agents is its rapid onset of action, which may lead to its use as the relaxant of choice when rapid intubation is required. An additional advantage is that, unlike other amino-steroidal NDNMBAs,
openaire +1 more source
Rocuronium is a new nondepolarizing neuromuscular blocking agent (NDNMBA) that has recently been introduced for clinical use. Its main advantage over other such agents is its rapid onset of action, which may lead to its use as the relaxant of choice when rapid intubation is required. An additional advantage is that, unlike other amino-steroidal NDNMBAs,
openaire +1 more source
Rocuronium in Emergent Intubation
Anesthesia & Analgesia, 2006C, Chamorro, M A, Romera, M, Valdivia
openaire +2 more sources
Rocuronium-Cisatracurium Combinations
Anesthesiology, 1999F, Donati, B, Plaud
openaire +2 more sources